DRMAW vs EFX
Dermata Therapeutics Inc. Warrant (DRMAW) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Equifax Inc (EFX) is a consulting services company listed on US.
DRMAW does not have a complete income-statement cache yet.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
DRMAW currently screens at market cap $0. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the DRMAW and EFX stock pages for the full models.
Not investment advice.